Name: Skye Bioscience, Inc. (SKYE) Balance Sheet
Creator: FinSpry

Skye Bioscience Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Skye Bioscience, Inc. (SKYE) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	68.42	1.26	1.24	8.98	2.47
Short-Term Investments	0.00	0.00	0.07	0.00	0.00
Cash & Short-Term Investments	68.42	1.26	1.24	8.98	2.47
Accounts Receivable	0.01	0.16	0.07	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	2.41	0.56	0.31	0.57	0.19
Total Current Assets	70.83	11.65	8.94	9.61	2.66
Non-Current Assets
Property, Plant & Equipment (Net)	1.88	0.28	0.16	0.23	0.01
Other Non-Current Assets	0.05	0.01	0.01	0.01	0.00
Total Non-Current Assets	1.94	0.29	0.17	0.24	0.00
Total Assets	72.76	11.94	9.11	9.86	2.67
Current Liabilities
Accounts Payable	0.57	0.96	1.79	0.90	0.36
Short-Term Debt	0.18	4.37	1.90	1.97	0.06
Current Portion of Long-Term Debt	0.00	0.00	1.85	1.97	0.06
Accrued Liabilities	1.77	7.53	0.76	0.90	0.32
Other Current Liabilities	3.59	0.97	7.48	0.06	0.04
Total Current Liabilities	4.34	13.90	12.12	3.91	0.79
Non-Current Liabilities
Long-Term Debt	0.27	0.17	0.00	0.08	1.43
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.27	0.17	0.00	0.08	0.00
Total Liabilities	4.61	14.07	12.12	3.99	2.22
Stockholders' Equity
Common Stock	0.03	0.01	0.00	0.48	0.29
Retained Earnings	-130.95	-104.38	-66.74	-47.26	-38.73
Additional Paid-in Capital	199.07	102.24	63.73	52.64	0.00
Shares Outstanding	30.97	12.35	3.65	1.90	0.00
Total Stockholders' Equity	68.15	-2.13	-3.01	5.86	0.45
Total Liabilities & Equity	72.76	11.94	9.11	9.86	0.00